Literature DB >> 15362335

Hemolysis with rapid transfusion systems in the trauma setting.

Peter Kim1, Ian Chin-Yee, Kathleen Eckert, Richard A Malthaner, Daryl K Gray.   

Abstract

OBJECTIVE: Rapid infusion system allows rapid infusion of resuscitation fluids at body temperature in trauma patients. Packed red blood cells are subjected to high external pneumatic pressure (up to 300 mm Hg) and rapid infusion rates through a 170-microm filter. This study was conducted to outline hemolysis that may occur in the setting of massive transfusion (> 10 units). METHODS AND MATERIALS: Measurements of various parameters were made before and after infusion of 17 units of outdated (38-82 d) packed red blood cells through a Level 1 Rapid Infuser, including lactate dehydrogenase (LDH), potassium, plasma hemoglobin, hematocrit and total hemoglobin. Hemolysis, expressed as a percentage, was calculated from these parameters.
RESULTS: Hemolysis observed in this experiment ranged from near 0 to 0.05%. All the units had plasma potassium concentrations of 15 mmol/L or more.
CONCLUSION: Transfusion of 17 units with the Level 1 Rapid Infuser did not cause a clinically significant amount of hemolysis.

Entities:  

Mesh:

Year:  2004        PMID: 15362335      PMCID: PMC3211793     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  10 in total

1.  Age of transfused blood is an independent risk factor for postinjury multiple organ failure.

Authors:  G Zallen; P J Offner; E E Moore; J Blackwell; D J Ciesla; J Gabriel; C Denny; C C Silliman
Journal:  Am J Surg       Date:  1999-12       Impact factor: 2.565

Review 2.  Fluid management in trauma.

Authors:  E Dahan; S Orbach; Y G Weiss
Journal:  Int Anesthesiol Clin       Date:  2000

3.  The effect of external pressure, catheter gauge, and storage time on hemolysis in RBC transfusion.

Authors:  R Frelich; M H Ellis
Journal:  Transfusion       Date:  2001-06       Impact factor: 3.157

4.  Hyperkalemic death during use of a high-capacity fluid warmer for massive transfusion.

Authors:  L C Jameson; P M Popic; B A Harms
Journal:  Anesthesiology       Date:  1990-11       Impact factor: 7.892

5.  Red cell viability with infusion systems.

Authors:  T L Simon; W McDonough; M K Warthen
Journal:  Transfusion       Date:  1994-03       Impact factor: 3.157

6.  Effect of an infusion device on the integrity of whole blood and packed red blood cells.

Authors:  K J Burch; S J Phelps; T D Constance
Journal:  Am J Hosp Pharm       Date:  1991-01

Review 7.  Hypothermia, coagulopathy, and acidosis.

Authors:  V A Eddy; J A Morris; D C Cullinane
Journal:  Surg Clin North Am       Date:  2000-06       Impact factor: 2.741

8.  The 24-hour posttransfusion survival, oxygen transport function, and residual hemolysis of human outdated-rejuvenated red cell concentrates after washing and storage at 4 degrees C for 24 to 72 hours.

Authors:  C R Valeri; A D Gray; G P Cassidy; W Riordan; L E Pivacek
Journal:  Transfusion       Date:  1984 Jul-Aug       Impact factor: 3.157

9.  The rapid infusion system: a superior method for the resuscitation of hypovolemic trauma patients.

Authors:  C M Dunham; H Belzberg; R Lyles; L Weireter; D Skurdal; G Sullivan; T Esposito; M Namini
Journal:  Resuscitation       Date:  1991-04       Impact factor: 5.262

10.  Electrolyte and acid-base disturbances caused by blood transfusions.

Authors:  K Linko; I Saxelin
Journal:  Acta Anaesthesiol Scand       Date:  1986-02       Impact factor: 2.105

  10 in total
  2 in total

1.  Technological advancements in the care of the trauma patient.

Authors:  J J Siracuse; N N Saillant; C J Hauser
Journal:  Eur J Trauma Emerg Surg       Date:  2011-11-09       Impact factor: 3.693

2.  Pressure Infusion Cuff and Blood Warmer during Massive Transfusion: An Experimental Study About Hemolysis and Hypothermia.

Authors:  Thomas G Poder; Denise Pruneau; Josée Dorval; Louis Thibault; Jean-François Fisette; Suzanne K Bédard; Annie Jacques; Patrice Beauregard
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.